Zobrazeno 1 - 6 of 6 pro vyhledávání: '"T. J. Lorenz"'
1
Immediate coronary artery bypass surgery after platelet inhibition with eptifibatide: results from PURSUIT. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrelin Therapy
Autor: C M, Dyke, D, Bhatia, T J, Lorenz, S P, Marso, B E, Tardiff, C, Hogeboom, R A, Harrington
Publikováno v: The Annals of thoracic surgery. 70(3)
The platelet GP IIb/IIIa inhibitor eptifibatide improves outcomes in patients with acute coronary syndromes. Patients requiring emergent coronary artery bypass grafting, however, may be at increased risk for bleeding if exposed to eptifibatide. Data
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::ccb4a40f7d4e1438dc2c974f6246d847
https://pubmed.ncbi.nlm.nih.gov/11016325
Zobrazit plný text záznamu
2
Early percutaneous coronary intervention, platelet inhibition with eptifibatide, and clinical outcomes in patients with acute coronary syndromes. PURSUIT Investigators
Autor: N S, Kleiman, A M, Lincoff, G C, Flaker, K S, Pieper, R G, Wilcox, L G, Berdan, T J, Lorenz, D V, Cokkinos, M L, Simoons, E, Boersma, E J, Topol, R M, Califf, R A, Harrington
Publikováno v: Circulation. 101(7)
Platelet glycoprotein (GP) IIb/IIIa antagonists prevent the composite end point of death or myocardial infarction (MI) in patients with acute coronary syndromes. There is uncertainty about whether this effect is confined to patients who have percutan
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::5540e3b187db79841e52dd07bead4f93
https://pubmed.ncbi.nlm.nih.gov/10683348
Zobrazit plný text záznamu
3
Inhibition of endotoxin-induced cytokine release and neutrophil activation in humans by use of recombinant bactericidal/permeability-increasing protein
Autor: M. A. M. von der Mohlen, A. N. Kimmings, N. I. Wedel, M. L. C. M. Mevissen, J. Jansen, N. Friedmann, T. J. Lorenz, B. J. Nelson, M. L. White, R. Bauer, C. E. Hack, A. J. M. Eerenberg, S. J. H. van Deventer
Publikováno v: The Journal of infectious diseases. 172(1)
To investigate the effects of a recombinant endotoxin-binding protein, bactericidal/permeability-increasing protein (rBPI23), on cytokine release and neutrophil activation in endotoxemia in humans, 8 volunteers were challenged twice with endotoxin an
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adc5886d61249ab6d9798c252541757b
https://pubmed.ncbi.nlm.nih.gov/7797904
Zobrazit plný text záznamu
4
Effects of administration of an anti-CD5 plus immunoconjugate in rheumatoid arthritis. Results of two phase II studies. The CD5 Plus Rheumatoid Arthritis Investigators Group
Autor: V, Strand, P E, Lipsky, G W, Cannon, L H, Calabrese, C, Wiesenhutter, S B, Cohen, N J, Olsen, M L, Lee, T J, Lorenz, B, Nelson
Publikováno v: Arthritis and rheumatism. 36(5)
To evaluate the safety and activity of an immunoconjugate of ricin A chain and anti-CD5 monoclonal antibody (anti-CD5 IC), with and without concomitant methotrexate and/or azathioprine, in the treatment of rheumatoid arthritis (RA).Seventy-nine patie
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::9816eaf6413ee7c9612b69cfa2116635
https://pubmed.ncbi.nlm.nih.gov/7683881
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje